- Bollore’s organic revenue experienced a significant decrease of 24% in the third quarter.
- The company’s revenue for this period amounted to 630 million euros.
- Among analysts, the stock has received mixed ratings: 1 “buy” rating, 4 “hold” ratings, and 1 “sell” rating.
A look at Bollore SA Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 5 | |
| Dividend | 2 | |
| Growth | 2 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.2 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Bollore SA is positioned for a favorable long-term outlook. With a top score in the Value category, the company is considered to be offering strong value relative to its market price. This indicates a potential for solid returns for investors looking for undervalued opportunities in the market.
While the Dividend and Growth scores are moderate, Bollore SA excels in Resilience, showcasing its ability to weather market volatility and economic challenges. Additionally, the company’s Momentum score suggests a steady performance trajectory. Overall, Bollore SA‘s diverse business portfolio, including freight forwarding, transport services, manufacturing, and banking, positions it well for sustained growth and stability in the long run.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
